Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Konishcheva (Moscow, Russian Federation), V. Gervazieva (Moscow, Russian Federation). Parameters of sIgE and sIgG4-autoAbs to lung elastin, collagen type III and myosin in bronchial asthma in association with chronic infection.. 3349

Member's Comments

No comment yet.

Related content which might interest you: Collagen type III content in large airways and distal lung of fatal asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010 Type I and III collagen protein precursors in the airways of smokers and COPD-patients Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008 Elevated type I collagen degradation predicts persistent asthma in children Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Bronchial inflammatory changes in wheezy infants Source: Annual Congress 2007 - Bronchial inflammation in wheezing infants and pre-school children Year: 2007 Osteopontin expression and relation to disease severity in human asthma Source: Eur Respir J 2011; 37: 331 Year: 2011 Polymerized type I collagen reverts airway hyperresponsiveness development in a guinea pig asthma model Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 C-reactive protein and the type IV collagen measurementin severe COPD: Value of roflumilast Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1393-1402 Year: 2015 Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD Source: Eur Respir J 2009; 34: 616 Year: 2009 Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone Source: Eur Respir J 2004; 24: 107-115 Year: 2004 A neo-epitope of collagen type VII (C7) is elevated in serum of patients with COPD and SSC Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Collagen and elastin turnover increase at COPD exacerbation irrespectively its etiology Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Expression of type 1 and type 2 cytokines in central airways of smokers with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001 Association between airway inflammation, disease control and lung function parameters in asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Models of asthma employing ovalbumin in rats and mice: similarities and differences compared with patient asthma Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005 Changes in bronchial mucous membrane depending on the stage of COPD (I, II) Source: Annual Congress 2011 - COPD mechanisms Year: 2011